UNSPSC 51284507: Lincomycin hydrochloride

This classification denotes a lincosamide antibiotic with the molecular formula C18H34N2O6S.ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M6T05Z2B68, chemically known as lincolnensin, hydrochloride, hemihydrate but more generally known as lincomycin hydrochloride, which bears US NIH Compound Identifier 3928. European Medicines Agency schedules Lincomycin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02924MIG.

UNSPSC 51284507 Lincomycin hydrochloride is a Commodity code that does not align with the recent state and local contract opportunities posted under it. The code nominally identifies a specific antibiotic pharmaceutical, but the most recent opportunities solicited under this code—naloxone procurement, direct-to-manufacturer pharmacy programs, general medical and first aid supplies, and multi-source generic pharmaceuticals—do not involve lincomycin hydrochloride or any single-drug procurement. The mismatch suggests that issuing bodies have applied this code to broader pharmaceutical and medical supply categories, or that the tagging reflects administrative classification rather than the actual product being purchased.

The recent activity shows issuing bodies spanning county health departments, state health and human services commissions, municipal fire departments, and cooperative purchasing alliances. Seminole County, Florida (IFB posted June 30, 2026, due July 26, 2023) solicited naloxone and drug deactivation systems through competitive sealed bidding; the Texas Health and Human Services Commission (RFI posted April 3, 2026) sought vendor capabilities for direct-to-manufacturer prescription programs; the City of Tampa (IFB posted March 25, 2026, due March 13, 2026) bid medical and first aid supplies for the Fire Department Rescue Division under a Small Local Business Enterprise set-aside with a $700,000 estimated contract amount; and the Minnesota Multistate Cooperative Purchasing Alliance (RFP posted January 20, 2026, due March 26, 2026) sought generic multi-source pharmaceuticals and OTC products for distribution across state and local facilities in Minnesota and Oregon. Geographic activity centers on Florida, Texas, and Minnesota, with cooperative purchasing extending to Oregon. This code shows little relevant recent activity tied to lincomycin hydrochloride specifically; buyers appearing under it are sourcing broader pharmaceutical, medical supply, and pharmacy program services that do not match the code's nominal scope.